
    
      At the completion of the Week-12 visit of the pivotal study (Baseline [Day 1] in this study),
      all eligible subjects will be offered enrollment in the long-term extension study. Study
      visits during the treatment period for all subjects will occur every 4 weeks (Â± 3 days). The
      total duration of study participation will be approximately 44 weeks.
    
  